• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Off-label drug use and promotion: balancing public health goals and commercial speech.

作者信息

Kesselheim Aaron S

机构信息

Harvard Medical School, USA.

出版信息

Am J Law Med. 2011;37(2-3):225-57. doi: 10.1177/009885881103700202.

DOI:10.1177/009885881103700202
PMID:21847880
Abstract
摘要

相似文献

1
Off-label drug use and promotion: balancing public health goals and commercial speech.药品的非标签使用与推广：平衡公共卫生目标与商业言论
Am J Law Med. 2011;37(2-3):225-57. doi: 10.1177/009885881103700202.
2
Off-label prescription advertising, the FDA and the First Amendment: a study in the values of commercial speech protection.非标签处方广告、美国食品药品监督管理局与第一修正案：商业言论保护价值研究
Am J Law Med. 2011;37(2-3):315-57. doi: 10.1177/009885881103700206.
3
Hidden truth: The perils and protection of off-label drug and medical device promotion.隐藏的真相：药品和医疗器械非标签推广的风险与防范
Health Matrix Clevel. 2011;21(1):149-87.
4
Off-label promotion: government theories of prosecution and facts that drive them.药品未按批准说明书用药的推广：政府的起诉理论及推动这些理论的事实。
Food Drug Law J. 2010;65(3):555-88.
5
The commercial speech doctrine in health regulation: the clash between the public interest in a robust First Amendment and the public interest in effective protection from harm.健康监管中的商业言论原则：第一修正案所保障的强大公众利益与有效预防伤害的公众利益之间的冲突。
Am J Law Med. 2011;37(2-3):299-314. doi: 10.1177/009885881103700205.
6
The future of off-label marketing regulations in the post-Sorrell era.索雷尔时代之后非标签营销法规的未来。
Seton Hall Law Rev. 2013;43(3):1137-63.
7
Manufacturers' promotion of off-label drug use: implications for drug safety.制造商对药品非标签使用的推广：对药物安全性的影响。
Expert Opin Drug Saf. 2016 Sep;15(9):1149-51. doi: 10.1080/14740338.2016.1186642. Epub 2016 May 23.
8
After Amarin v FDA: What Will the Future Hold for Off-label Promotion Regulation?阿玛林公司诉美国食品药品监督管理局之后：药品未按批准说明用药推广监管的未来走向如何？
Mayo Clin Proc. 2016 Jun;91(6):701-6. doi: 10.1016/j.mayocp.2016.02.024. Epub 2016 Apr 12.
9
Bias at the gate?: The pharmaceutical industry's influence on the federally approved drug compendia.
Am J Law Med. 2014;40(1):141-63. doi: 10.1177/009885881404000105.
10
Evaluating promotional claims as false or misleading.评估促销宣传是否虚假或具有误导性。
Am J Health Syst Pharm. 2013 Nov 1;70(21):1941-4. doi: 10.2146/ajhp130076.

引用本文的文献

1
Prevalence of pharmaceutical industry conspiracy theories among the polish population.波兰民众中制药行业阴谋论的流行程度。
Sci Rep. 2025 Mar 29;15(1):10857. doi: 10.1038/s41598-025-95626-2.
2
Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review.运动员超说明书用药的安全性影响：一项叙述性综述
Medicines (Basel). 2024 Nov 15;11(8):20. doi: 10.3390/medicines11080020.
3
Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.直接面向消费者的药品广播广告：标签外推广和遵守 FDA 指南。
J Gen Intern Med. 2018 May;33(5):651-658. doi: 10.1007/s11606-017-4274-9. Epub 2018 Feb 26.
4
In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris.氯吡格雷普通剂型与品牌剂型对稳定型心绞痛患者血小板聚集的体外抑制作用
J Cardiovasc Thorac Res. 2017;9(4):191-195. doi: 10.15171/jcvtr.2017.33. Epub 2017 Oct 10.
5
Considering the Future of Pharmaceutical Promotions in Social Media Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". 考虑医药推广在社交媒体的未来 评“在线直接面向消费者的处方药促销的问题点：FDA 警告信的内容分析”。
Int J Health Policy Manag. 2016 Feb 9;5(4):283-5. doi: 10.15171/ijhpm.2016.15.
6
The First Amendment Right to Speak About the Human Genome.关于人类基因组言论的第一修正案权利。
Univ Pa J Const Law. 2014 Feb 1;16(3):549-636.
7
Development and use of new therapeutics for rare diseases: views from patients, caregivers, and advocates.罕见病新疗法的研发与应用：患者、照料者及倡导者的观点
Patient. 2015 Feb;8(1):75-84. doi: 10.1007/s40271-014-0096-6.
8
Ethical issues in new drug prescribing.新药处方中的伦理问题。
J Bioeth Inq. 2012 Mar;9(1):77-83. doi: 10.1007/s11673-011-9342-y. Epub 2011 Dec 15.